BIO Asia - Taiwan
July 15-19, 2026, Taiwan
Asia's largest bioindustry-focused gathering, BIO Asia–Taiwan 2026, will be held July 15-19, 2026, in Taipei. Co-organized by BIO (US-based global Biotechnology Innovation Organization) and Taiwan BIO (Taiwan Bio Industry Organization), executives, researchers and investors from North America, Europe, and Asia will come together to explore opportunities within Asia's thriving biotech sector. This year's theme, Embracing Asian Dynamics, highlights Asian's fast-moving economies and dynamic biomedical ecosystems, and its globally-connected production and value chains.
Asia Bio Partnering Forum
September 1–2, 2026，Marina Bay Sands, Singapore
Asia Bio Partnering Forum is your gateway to Asia's emerging innovation. Asia Bio Partnering Forum will continue to build on its strong start and will gather biotech and pharma leaders from around the world with hundreds of emerging innovators across Asia Pacific to advance dealmaking in Asia.
The 2026 CPCIC China Pharmaceutical Commercialization
September 22–23, 2026，Shanghai China
The 2026 CPCIC China Pharmaceutical Commercialization Innovation Conference, themed "Driven by Digital Intelligence, Innovated Through Collaboration, Coexisting for Shared Value", will be held in Shanghai on September 22–23, 2026. Centered on three core sectors—digital pharmaceutical marketing, pharmaceutical logistics and supply chain, as well as innovative payment and health insurance—the conference is expected to gather over 800 leaders and practitioners engaged in pharmaceutical commercialization to discuss parallel transformation and in-depth integration across the three fields.
Bio Japan
2026 Oct 7-9, PACIFICO Yokohama
BioJapan is Asia's premier bio-industry partnering event, comprising an Exhibition, Seminars, and Partnering sessions.
As the world's longest-running biotech exhibition, BioJapan, along with its two co-located events —Regenerative Medicine Japan, which accelerates R&D and commercialization in regenerative medicine, and healthTECH Japan, focusing on health management, diagnostics, and therapeutics through the integration of digital technology and life sciences— continues to drive innovation and collaboration in the industry.
BioCentury-BayHelix China Healthcare Summit
November 2-4, 2026, Shanghai, China
From cross-border deals to newcos, faster clinical data is fueling the China innovation story, turning biopharmas from Shanghai to Beijing into global players. Multinational pharma and Western VCs have been the first to capitalize, sourcing innovation from China at record levels.
But testing faster in humans is also a recipe for Western and Asia biotechs to de-risk their own compounds, working with China partners.
This November, BioCentury, BayHelix and Insights Partner McKinsey & Company invite you to visit Shanghai for the 13th China Healthcare Summit. Get a firsthand look at China's biotech ecosystem and build your network with the right biopharmas, investors and CDMOs.
But testing faster in humans is also a recipe for Western and Asia biotechs to de-risk their own compounds, working with China partners.
This November, BioCentury, BayHelix and Insights Partner McKinsey & Company invite you to visit Shanghai for the 13th China Healthcare Summit. Get a firsthand look at China's biotech ecosystem and build your network with the right biopharmas, investors and CDMOs.
BIO-Europe
November 9–11, 2026, Cologne, Germany
oin us for the 32nd BIO-Europe in Cologne, Germany, November 9–11, 2026—the premier biopharma partnering event, now expanded into a comprehensive forum for the entire biotech ecosystem.
BIO-Europe 2026 convenes the biotech pharma C-suite with seven parallel content tracks covering partnering, investment, therapeutic areas, regulatory developments, clinical affairs, and manufacturing strategy. Daily plenary sessions address macro-level industry and policy trends, while new access options support different levels of engagement.
A new Content-Only registration is now available for non-partnering attendees, providing access to the exhibit hall, all program tracks, and the Monday evening event. All-Access attendees enjoy the full partnering experience. Join us to strengthen leadership, champion innovation, and foster the global partnerships that drive our industry forward.
BIO-Europe 2026 convenes the biotech pharma C-suite with seven parallel content tracks covering partnering, investment, therapeutic areas, regulatory developments, clinical affairs, and manufacturing strategy. Daily plenary sessions address macro-level industry and policy trends, while new access options support different levels of engagement.
A new Content-Only registration is now available for non-partnering attendees, providing access to the exhibit hall, all program tracks, and the Monday evening event. All-Access attendees enjoy the full partnering experience. Join us to strengthen leadership, champion innovation, and foster the global partnerships that drive our industry forward.
Media Partners
